Citation Impact
Citing Papers
Acute Phase Proteins with Special Reference to C-Reactive Protein and Related Proteins (Pentaxins) and Serum Amyloid A Protein
1983 Standout
OCEANS: A Randomized, Double-Blind, Placebo-Controlled Phase III Trial of Chemotherapy With or Without Bevacizumab in Patients With Platinum-Sensitive Recurrent Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
2012 Standout
Pegylated Liposomal Doxorubicin and Carboplatin Compared With Paclitaxel and Carboplatin for Patients With Platinum-Sensitive Ovarian Cancer in Late Relapse
2010
Frequent Mutations of Chromatin Remodeling Gene ARID1A in Ovarian Clear Cell Carcinoma
2010 StandoutScience
Phase III Trial of Carboplatin and Paclitaxel Compared With Cisplatin and Paclitaxel in Patients With Optimally Resected Stage III Ovarian Cancer: A Gynecologic Oncology Group Study
2003 Standout
Preinvasive and invasive ductal pancreatic cancer and its early detection in the mouse
2003 Standout
Survival Effect of Maximal Cytoreductive Surgery for Advanced Ovarian Carcinoma During the Platinum Era: A Meta-Analysis
2002 Standout
Primary chemotherapy versus primary surgery for newly diagnosed advanced ovarian cancer (CHORUS): an open-label, randomised, controlled, non-inferiority trial
2015 Standout
A new genetic algorithm technique in optimization of permanent prostate implants
1998
A binary histologic grading system for ovarian serous carcinoma is an independent prognostic factor: A population-based study of 4317 women diagnosed in Denmark 1978–2006
2012
Etoposide: four decades of development of a topoisomerase II inhibitor
1998 Standout
Quality of Life and Satisfaction with Outcome among Prostate-Cancer Survivors
2008 Standout
The clinical pharmacology of etoposide
1991
The effect of seed orientation deviations on the quality of125I prostate implants
2001
The role of liposomes in clinical nanomedicine development. What now? Now what?
2019 Standout
Endometriosis-Associated Ovarian Carcinoma (EAOC): An Entity Distinct from Other Ovarian Carcinomas as Suggested by a Nested Case-Control Study
2001
Ovarian cancer
2014 Standout
Salvage brachytherapy for localized prostate cancer after radiotherapy failure
1999
Role of surgical outcome as prognostic factor in advanced epithelial ovarian cancer: A combined exploratory analysis of 3 prospectively randomized phase 3 multicenter trials
2009 Standout
A history of prostate cancer treatment
2002
Brachytherapy for carcinoma of the prostate: Techniques, patient selection, and clinical outcomes
2002
Biochemical Outcome After Radical Prostatectomy, External Beam Radiation Therapy, or Interstitial Radiation Therapy for Clinically Localized Prostate Cancer
1998 Standout
Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survival
2003 Standout
Distinct Populations of Cancer Stem Cells Determine Tumor Growth and Metastatic Activity in Human Pancreatic Cancer
2007 Standout
Ondansetron plus Metopimazine Compared with Ondansetron Alone in Patients Receiving Moderately Emetogenic Chemotherapy
1993
Trp53R172H and KrasG12D cooperate to promote chromosomal instability and widely metastatic pancreatic ductal adenocarcinoma in mice
2005 Standout
Long-term results of interstitial brachytherapy (LDR-Brachytherapy) in the treatment of patients with prostate cancer
2006
Prostate-specific deletion of the murine Pten tumor suppressor gene leads to metastatic prostate cancer
2003 Standout
The Role of Adjuvant Radiotherapy in Carcinoma of the Endometrium—Results in 550 Patients with Pathologic Stage I Disease
1998
A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: a Gynecologic Oncology Group study
2004 Standout
Conformity index: A review
2006 Standout
Permanent prostate seed implant brachytherapy: Report of the American Association of Physicists in Medicine Task Group No. 64
1999
Impact on survival of 12 versus 3 monthly cycles of paclitaxel (175 mg/m2) administered to patients with advanced ovarian cancer who attained a complete response to primary platinum-paclitaxel: Follow-up of a Southwest Oncology Group and Gynecologic Oncology Group phase 3 trial
2009
Developmental chemotherapy in advanced ovarian cancer: Incorporation of newer cytotoxic agents in a phase III randomized trial of the Gynecologic Oncology Group (GOG-0182)
2002
EAU Guidelines on Prostate Cancer
2007 Standout
Chemotherapy-Induced Nausea and Vomiting
2008 Standout
Transrectal ultrasound in the diagnosis and staging of local disease after I125 seed implantation for prostate cancer
1988
Randomised trial of self-expanding metal stents versus polyethylene stents for distal malignant biliary obstruction
1992 Standout
Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: multicentre randomised trial
2000 Standout
Dose-effect study of carboplatin in ovarian cancer: a Danish Ovarian Cancer Group study.
1997
A conformation number to quantify the degree of conformality in brachytherapy and external beam irradiation: Application to the prostate
1997
Update of AAPM Task Group No. 43 Report: A revised AAPM protocol for brachytherapy dose calculations
2004 Standout
Olaparib Maintenance Therapy in Platinum-Sensitive Relapsed Ovarian Cancer
2012 Standout
Integral-transport-based deterministic brachytherapy dose calculations
2002
Interstitial iodine-125 radiation without adjuvant therapy in the treatment of clinically localized prostate carcinoma
1997
Pancreatic Carcinoma
1992
Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: Recommendations of the RTOG-ASTRO Phoenix Consensus Conference
2006 Standout
Neoadjuvant Chemotherapy or Primary Surgery in Stage IIIC or IV Ovarian Cancer
2010 Standout
Dynamic regulation of FoxP3 expression controls the balance between CD4+ T cell activation and cell death
2005 StandoutNobel
Cancer of the Ovary
2004 Standout
Presalvage prostate‐specific antigen (PSA) and PSA doubling time as predictors of biochemical failure of salvage cryotherapy in patients with locally recurrent prostate cancer after radiotherapy
2006 Standout
Hypoxia-Inducible Factor 1 Regulates Vascular Endothelial Growth Factor Expression in Human Pancreatic Cancer
2003 StandoutNobel
Acute phase reactants and complement components as indicators of recurrence in human cervical cancer
1979
Prediction of Drug Absorption Using Multivariate Statistics
2000 Standout
Phase III Randomized Trial of 12 Versus 3 Months of Maintenance Paclitaxel in Patients With Advanced Ovarian Cancer After Complete Response to Platinum and Paclitaxel-Based Chemotherapy: A Southwest Oncology Group and Gynecologic Oncology Group Trial
2003
Topotecan Compared With No Therapy After Response to Surgery and Carboplatin/Paclitaxel in Patients With Ovarian Cancer: Multicenter Italian Trials in Ovarian Cancer (MITO-1) Randomized Study
2004
Prediction of Human Intestinal Absorption of Drug Compounds from Molecular Structure
1998
Induction of remission in hepatocellular carcinoma: A comparison of VP 16 with adriamycin
1983
Dendritic cells expand antigen‐specific Foxp3+CD25+CD4+ regulatory T cells including suppressors of alloreactivity
2006 StandoutNobel
Design of Density Functionals by Combining the Method of Constraint Satisfaction with Parametrization for Thermochemistry, Thermochemical Kinetics, and Noncovalent Interactions
2006 Standout
Intraperitoneal Cisplatin and Paclitaxel in Ovarian Cancer
2006 Standout
VP-16-213 (etoposide): The mandrake root from Issyk-Kul
1982
Future of Cancer Incidence in the United States: Burdens Upon an Aging, Changing Nation
2009 Standout
Prostate Specific Antigen Based Disease Control Following Ultrasound Guided sup 125 Iodine Implantation for Stage T1/T2 Prostatic Carcinoma
1995
Phase III Trial of Observation Versus Six Courses of Paclitaxel in Patients With Advanced Epithelial Ovarian Cancer in Complete Response After Six Courses of Paclitaxel/Platinum-Based Chemotherapy: Final Results of the After-6 Protocol 1
2009
Works of I. Strøyer being referenced
Ultrasonically guided percutaneous implantation of iodine-125 seeds in pancreatic carcinoma
1990
A Prospective Randomized Comparison of 6 and 12 Cycles of Cyclophosphamide, Adriamycin, and Cisplatin in Advanced Epithelial Ovarian Cancer: A Danish Ovarian Study Group Trial (DACOVA)
1993
Prognostic factors and adjuvant treatment in early epithelial ovarian cancer
1993
Transperineal 125 Iodine Seed Implantation in Prostatic Cancer Guided by Transrectal Ultrasonography
1983
C1-ESTERASE INACTIVATORS AND C4 IN MALIGNANT DISEASES
1975
Clinical trial of the oral form of a new podophyllotoxin derivative, VP-16-213 (NSC-141540), in patients with advanced neoplastic disease.
1976
[Clinical evaluation of an antiemetic, metopimazine (Vogalene) in an open and double-blind trial].
1976
Adjuvant radiation therapy is not necessary in the management of endometrial carcinoma stage I, low-risk cases
1996